BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND XPC, XP3, 7508, ENSG00000154767, XPCC
25 results:

  • 1. Genetic variations in DNA excision repair pathway contribute to the chemosensitivity and prognosis of acute myeloid leukemia.
    Zhang A; Liu W; Guo X; Jia H; Wei Y; Can C; He N; Ji C; Ma D
    Clin Chim Acta; 2024 May; 558():117899. PubMed ID: 38574942
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Increased risk of internal tumors in DNA repair-deficient xeroderma pigmentosum patients: analysis of four international cohorts.
    Nikolaev S; Yurchenko AA; Sarasin A
    Orphanet J Rare Dis; 2022 Mar; 17(1):104. PubMed ID: 35246173
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Association of DNA repair gene xpc Ala499Val (rs2228000 C>T) and Lys939Gln (rs2228001 A>C) polymorphisms with the risk of chronic myeloid leukemia: A case-control study in a South Indian population.
    Lakkireddy S; Aula S; Kapley A; Gundeti S; Kutala VK; Jamil K
    J Gene Med; 2021 Jul; 23(7):e3339. PubMed ID: 33829606
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. xpc deficiency increases risk of hematologic malignancies through mutator phenotype and characteristic mutational signature.
    Yurchenko AA; Padioleau I; Matkarimov BT; Soulier J; Sarasin A; Nikolaev S
    Nat Commun; 2020 Nov; 11(1):5834. PubMed ID: 33203900
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Effect of Dasatinib on Genes Related to Mitotic Catastrophe Pathway in Chronic Myeloid leukemia Cells.
    Kipcak S; Ozel B; Avci CB; Takanlou LS; Takanlou MS; Gunduz C; Gunel NS
    Anticancer Agents Med Chem; 2021; 21(13):1724-1731. PubMed ID: 33155931
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cellular and molecular architecture of hematopoietic stem cells and progenitors in genetic models of bone marrow failure.
    Heidemann S; Bursic B; Zandi S; Li H; Abelson S; Klaassen RJ; Abish S; Rayar M; Breakey VR; Moshiri H; Dhanraj S; de Borja R; Shlien A; Dick JE; Dror Y
    JCI Insight; 2020 Feb; 5(4):. PubMed ID: 31990679
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genetic variants of nucleotide excision repair pathway and outcomes of induction therapy in acute myeloid leukemia.
    Sharifi Z; Faranoush M; Mohseni A; Rostami S; Ramzi M; Sharifi MJ
    Per Med; 2019 Nov; 16(6):479-490. PubMed ID: 31647372
    [No Abstract]    [Full Text] [Related]  

  • 8. The protective role of DOT1L in UV-induced melanomagenesis.
    Zhu B; Chen S; Wang H; Yin C; Han C; Peng C; Liu Z; Wan L; Zhang X; Zhang J; Lian CG; Ma P; Xu ZX; Prince S; Wang T; Gao X; Shi Y; Liu D; Liu M; Wei W; Wei Z; Pan J; Wang Y; Xuan Z; Hess J; Hayward NK; Goding CR; Chen X; Zhou J; Cui R
    Nat Commun; 2018 Jan; 9(1):259. PubMed ID: 29343685
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. DNA repair gene expressions are related to bone marrow cellularity in myelodysplastic syndrome.
    Ribeiro HL; Maia ARS; de Oliveira RTG; Costa MB; Farias IR; de Paula Borges D; de Sousa JC; Magalhães SMM; Pinheiro RF
    J Clin Pathol; 2017 Nov; 70(11):970-980. PubMed ID: 28554891
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Influence of xpc, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population.
    Bănescu C; Iancu M; Trifa AP; Dobreanu M; Moldovan VG; Duicu C; Tripon F; Crauciuc A; Skypnyk C; Bogliș A; Lazar E
    Tumour Biol; 2016 Jul; 37(7):9357-66. PubMed ID: 26779634
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Arsenic Disruption of DNA Damage Responses-Potential Role in Carcinogenesis and Chemotherapy.
    Muenyi CS; Ljungman M; States JC
    Biomolecules; 2015 Sep; 5(4):2184-93. PubMed ID: 26404387
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Polymorphisms in xpc, XPD and XPG DNA repair genes and leukemia risk in a Tunisian population.
    Douzi K; Ouerhani S; Menif S; Safra I; Abbes S
    Leuk Lymphoma; 2015 Jun; 56(6):1856-62. PubMed ID: 25311495
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Polymorphisms in xpc provide prognostic information in acute myeloid leukemia.
    Xu P; Chen B; Feng J; Cheng L; Xia G; Li Y; Qian J; Ding J; Lu Z
    Int J Hematol; 2012 Oct; 96(4):450-60. PubMed ID: 22968471
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Gene expression profiling in MOLT-4 cells during gamma-radiation-induced apoptosis.
    Lindgren T; Stigbrand T; Riklund K; Johansson L; Eriksson D
    Tumour Biol; 2012 Jun; 33(3):689-700. PubMed ID: 22322922
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [The relationship between polymorphism of genes XPA, xpc, XPD, XRCC1 and susceptibility to acute lymphoblastic leukemia].
    Tang FF; Ouyang J; Xu Y; Zhou RF; Zhou M; Chen B; Zhang QG; Feng X; Zhang X; Chen MM; Zeng Y; Xu YY
    Zhonghua Nei Ke Za Zhi; 2011 Oct; 50(10):859-62. PubMed ID: 22321329
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. xpc genetic polymorphisms correlate with the response to imatinib treatment in patients with chronic phase chronic myeloid leukemia.
    Guillem VM; Cervantes F; Martínez J; Alvarez-Larrán A; Collado M; Camós M; Sureda A; Maffioli M; Marugán I; Hernández-Boluda JC
    Am J Hematol; 2010 Jul; 85(7):482-6. PubMed ID: 20575039
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Acute myeloid leukemia outcome: role of nucleotide excision repair polymorphisms in intermediate risk patients.
    Strom SS; Estey E; Outschoorn UM; Garcia-Manero G
    Leuk Lymphoma; 2010 Apr; 51(4):598-605. PubMed ID: 20141440
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Transcriptional response of genes involved in cell defense system in human cells stressed by H2O2 and pre-treated with (Tunisian) Rhamnus alaternus extracts: combination with polyphenolic compounds and classic in vitro assays.
    Ammar RB; Bouhlel I; Valenti K; Sghaier MB; Kilani S; Mariotte AM; Dijoux-Franca MG; Laporte F; Ghedira K; Chekir-Ghedira L
    Chem Biol Interact; 2007 Jul; 168(3):171-83. PubMed ID: 17512922
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Role of MTHFR (677, 1298) haplotype in the risk of developing secondary leukemia after treatment of breast cancer and hematological malignancies.
    Guillem VM; Collado M; Terol MJ; Calasanz MJ; Esteve J; Gonzalez M; Sanzo C; Nomdedeu J; Bolufer P; Lluch A; Tormo M
    Leukemia; 2007 Jul; 21(7):1413-22. PubMed ID: 17476281
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Cytogenetic characteristics of patients with signs and symptoms of myelodysplastic syndromes in the State of Pará, Brazil.
    Pinto GR; Overal DJ; Moraes LS; Van Den Berg AV; Lemos JA; Smith Mde A; Burbano RR
    Genet Mol Res; 2005 Mar; 4(1):18-30. PubMed ID: 15841432
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.